Is Adial Pharmaceuticals Inc (ADIL) undervalued? · $6.0M cap
Adial Pharmaceuticals Inc (ADIL) is a biotechnology company listed on NASDAQ.
This page asks whether Adial Pharmaceuticals Inc (ADIL) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Without a cached income statement, “undervalued ADIL” is a slogan. Wait for the print.
ADIL currently screens at market cap $6.0M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new ADIL 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare ADIL to the stock page model before you treat a low multiple as a gift.
Not investment advice.